Avantor, Inc.

NYSE:AVTR

Laboratory Analytical Instruments·RADNOR, PA

Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania.

CFO

Jones R. Brent

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/11/26	→
10-Q	Q3 2025	9/30/25	10/29/25	→
10-Q	Q2 2025	6/30/25	8/1/25	→
10-Q	Q1 2025	3/31/25	4/25/25	→
10-K	FY 2024	12/31/24	2/7/25	→
10-Q	Q3 2024	9/30/24	10/25/24	→
↓

Earnings Releases (8-K)

27 shown

Filed	Period
2/11/26	Q1 FY2026	→
10/29/25	Q3 FY2025	→
8/1/25	Q3 FY2025	→
4/25/25	Q1 FY2025	→
2/7/25	Q1 FY2025	→
10/25/24	Q3 FY2024	→
↓

News (8-K)

53 shown

Filed	Type	Description
2/25/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
2/25/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/18/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/4/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/10/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/14/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

29 shown

Filed	Form	Description
3/28/25	ARS	ARS	→
3/29/24	ARS	ARS	→
3/31/23	ARS	ARS	→
9/15/21	424B5	424B5	→
9/13/21	424B5	424B5	→
9/13/21	POSASR	POSASR	→
↓

Filing History(742 filings)

TypeDateAccessionPeriodSize

Feb 25, 2026

0001628280-26-011812FORM 4

Feb 23, 2026

4.9 KB

Feb 25, 2026

0001628280-26-011811FORM 4

Feb 23, 2026

6.2 KB

Feb 25, 2026

0001628280-26-011810FORM 4

Feb 23, 2026

4.9 KB

Feb 25, 2026

0001628280-26-011809FORM 4

Feb 23, 2026

4.9 KB

Feb 25, 2026

0001628280-26-011808FORM 4

Feb 23, 2026

6.3 KB

8-K/A

Feb 25, 2026

0001628280-26-0117278-K/A

Dec 17, 2025

374.9 KB

8-K/A

Feb 25, 2026

0001628280-26-0117228-K/A

Dec 4, 2025

374.9 KB

Feb 23, 2026

0001628280-26-010833FORM 4

Feb 19, 2026

8.5 KB

Feb 23, 2026

0001628280-26-010832FORM 4

Feb 19, 2026

6.1 KB

Feb 23, 2026

0001628280-26-010831FORM 4

Feb 19, 2026

7.0 KB

Feb 23, 2026

0001628280-26-010830FORM 4

Feb 19, 2026

8.5 KB

Feb 23, 2026

0001628280-26-010829FORM 4

Feb 19, 2026

7.0 KB

Feb 23, 2026

0001628280-26-010828FORM 4

Feb 19, 2026

8.5 KB

Feb 23, 2026

0001628280-26-010827FORM 4

Feb 19, 2026

8.5 KB

Feb 23, 2026

0001628280-26-010826FORM 4

Feb 19, 2026

8.5 KB

Feb 23, 2026

0001628280-26-010825FORM 4

Feb 19, 2026

8.5 KB

Feb 12, 2026

0001628280-26-007802FORM 4

Feb 12, 2026

5.6 KB

8-K

Feb 11, 2026

0001628280-26-0071208-K

Feb 11, 2026

1.1 MB

10-K

Feb 11, 2026

0001628280-26-00711810-K

Dec 31, 2025

34.9 MB

Jan 12, 2026

0001628280-26-001871FORM 4

Jan 2, 2026

4.7 KB

Jan 12, 2026

0001628280-26-001870FORM 3

Jan 2, 2026

534.3 KB

8-K

Dec 18, 2025

0001628280-25-0578058-K

Dec 17, 2025

1.1 MB

Dec 9, 2025

0001628280-25-056173FORM 4

Dec 5, 2025

7.0 KB

Dec 9, 2025

0001628280-25-056167FORM 3

Dec 5, 2025

533.5 KB

8-K

Dec 4, 2025

0001722482-25-0002218-K

Dec 4, 2025

1.1 MB

25 filings shown

Filed	Form	Description
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/6/25	144	144	→
10/17/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/13/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/5/25	144	144	→
↓

Avantor, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(742 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/28/25	DEFA14A	DEFA14A	→
3/28/25	DEF 14A	DEF 14A	→
3/29/24	DEFA14A	DEFA14A	→
3/29/24	DEF 14A	DEF 14A	→
3/19/24	PRE 14A	PRE 14A	→
3/31/23	DEFA14A	DEFA14A	→
↓